Turning science into business: An optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
These vectors could carry larger payloads to increase the precision of therapeutic mRNA or gene editing machinery for CRISPR. Current approaches are largely focused on intrathecal delivery, but intravenous delivery with molecules that can cross the BBB would offer improved tolerability and compliance.
52 
Let's personalize your content